European Journal of Nuclear Medicine and Molecular Imaging,
Journal Year:
2022,
Volume and Issue:
49(13), P. 4616 - 4641
Published: July 5, 2022
Abstract
Targeted
radionuclide
theranostics
is
becoming
more
and
prominent
in
clinical
oncology.
Currently,
most
nuclear
medicine
compounds
researched
for
cancer
are
directed
towards
targets
expressed
only
a
small
subset
of
types,
limiting
applicability.
The
identification
cancer-specific
that
(more)
universally
will
allow
patients
to
benefit
from
these
personalized
medicine–based
interventions.
A
tumor
not
merely
collection
cells,
it
also
comprises
supporting
stromal
cells
embedded
an
altered
extracellular
matrix
(ECM),
together
forming
the
microenvironment
(TME).
Since
TME
less
genetically
unstable
than
phenotypes
can
be
shared
between
offers
expressed.
characterized
by
presence
processes
such
as
hypoxia,
acidity,
increased
metabolism.
Next
ECM,
consists
cancer-associated
fibroblasts
(CAFs),
macrophages,
endothelial
neo-vasculature,
immune
adipocytes
(CAAs).
Radioligands
at
processes,
cellular
components
have
been
developed
evaluated
preclinical
studies
targeted
imaging
and/or
therapy.
In
this
review,
we
provide
overview
their
corresponding
radioligands.
addition,
discuss
what
developments
needed
further
explore
target
theranostics,
with
hopes
stimulating
development
novel
radioligands
multi-cancer,
or
some
cases
even
pan-cancer,
application.
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: March 6, 2023
Prolonged
exposure
to
environmental
respirable
toxicants
can
lead
the
development
and
worsening
of
severe
respiratory
diseases
such
as
asthma,
chronic
obstructive
pulmonary
disease
(COPD)
fibrosis.
The
limited
number
FDA-approved
inhaled
drugs
for
these
serious
lung
conditions
has
led
a
shift
from
in
vivo
towards
use
alternative
vitro
human-relevant
models
better
predict
toxicity
particles
preclinical
research.
While
there
are
several
inhalation
upper
airways,
fragile
dynamic
nature
alveolar
microenvironment
reproducible
distal
lung.
Here,
we
present
mechanistic
approach
using
new
generation
systems,
Cloud
α
AX12.
This
novel
tool
consists
cloud-based
chamber
(VITROCELL)
that
integrates
breathing
AX
Lung-on-chip
system
(AlveoliX).
ultrathin
porous
membrane
AX12
plate
was
used
create
complex
multicellular
model
enables
key
physiological
culture
conditions:
air-liquid
interface
(ALI)
three-dimensional
cyclic
stretch
(CS).
Human-relevant
cellular
were
established
a)
alveolar-capillary
primary
cell-derived
immortalized
epithelial
cells
(
iAECs),
macrophages
(THP-1)
endothelial
(HLMVEC)
cells,
b)
upper-airways
Calu3
cells.
Primary
human
hAEpCs)
validate
results
obtained
cell
lines.
To
mimic
relevant
aerosol
exposures
with
AX12,
three
different
using:
titanium
dioxide
(TiO2)
zinc
oxide
nanoparticles
polyhexamethylene
guanidine
toxic
chemical
c)
an
anti-inflammatory
corticosteroid,
fluticasone
propionate
(FL).
Our
suggest
important
synergistic
effect
on
air-blood
barrier
sensitivity,
cytotoxicity
inflammation,
when
combined.
best
our
knowledge,
this
is
first
time
been
described
lung-on-chip
technology.
thus
represents
state-of-the-art
pre-clinical
study
risks,
drug
safety
efficacy.
Beilstein Journal of Nanotechnology,
Journal Year:
2025,
Volume and Issue:
16, P. 97 - 118
Published: Jan. 31, 2025
In
the
coming
decades,
development
of
nanocarriers
(NCs)
for
targeted
drug
delivery
will
mark
a
significant
advance
in
field
pharmacology.
NCs
can
improve
solubility,
ensure
precise
distribution,
and
enable
passage
across
biological
barriers.
Despite
these
potential
advantages,
interaction
with
many
matrices,
particularly
existing
macrophages,
must
be
considered.
this
review,
we
explore
dual
role
macrophages
NC
delivery,
highlighting
their
physiological
functions,
challenges
posed
by
mononuclear
phagocyte
system,
innovative
strategies
to
exploit
macrophage
interactions
therapeutic
advantage.
Recent
advancements
treating
liver
lung
diseases,
focusing
on
polarization
RNA-based
therapies,
have
highlighted
developments
macrophage-NC
interaction.
Furthermore,
delve
into
intriguing
nanomedicine
neurology
traumatology,
associated
interaction,
exciting
possibilities
it
holds
future.
Cells,
Journal Year:
2021,
Volume and Issue:
10(6), P. 1323 - 1323
Published: May 26, 2021
The
skin
is
our
largest
organ
and
the
outermost
protective
barrier.
Its
aging
reflects
both
intrinsic
extrinsic
processes
resulting
from
constant
insults
it
exposed
to.
Aging
in
accompanied
by
specific
epigenetic
modifications,
accumulation
of
senescent
cells,
reduced
cellular
proliferation/tissue
renewal,
altered
extracellular
matrix,
a
proinflammatory
environment
favoring
undesirable
conditions,
including
disease
onset.
Macrophages
(Mφ)
are
most
abundant
immune
cell
type
comprise
group
heterogeneous
plastic
cells
that
key
for
homeostasis
host
defense.
However,
they
have
also
been
implicated
orchestrating
chronic
inflammation
during
aging.
Since
Mφ
related
to
innate
adaptive
immunity,
possible
age-modified
promote
immunity
exacerbation
exhaustion,
emergence
pathologies,
such
as
cancer.
In
this
review,
we
will
highlight
recent
findings
pertaining
effects
hallmarks
over
Mφ,
supporting
recognition
types
driving
force
inflammaging
age-related
diseases.
We
present
research
targeting
potential
therapeutic
interventions
inflammatory
disorders
Autoimmunity Reviews,
Journal Year:
2021,
Volume and Issue:
20(10), P. 102911 - 102911
Published: July 20, 2021
Anti-neutrophil
cytoplasmic
antibodies
(ANCA)-associated
vasculitides
(AAV)
are
characterized
by
inflammation
of
small-to-medium-sized
blood
vessels
and
the
presence
autoantibodies
against
proteases
sited
in
neutrophils
monocytes.
Increasing
evidence
indicates
a
substantial
role
monocytes
macrophages
pathogenesis
AAV.
Activated
contribute
to
necroinflammation
peripheral
vasculitic
lesions
as
well
central
mechanisms
autoimmunity.
The
intermediate
monocyte
subset
(CD14++CD16+)
is
increased
show
elevated
expression
CD14,
Toll-like
receptor
2/4,
MHCII
integrins,
likely
reflecting
activation
extravasation.
Monocytes
differentiate
locally
predominantly
into
alternatively
activated
(M2)
macrophages,
which
known
for
cell-clearance
phagocytosis,
but
may
ultimately
lead
fibrosis.
Phagocytotic
function
can
be
impaired
surface
on
apoptotic
causes
release
inflammatory
cytokines
immunogenic
contents,
presumably
resulting
vicious
circle
neutrophil,
T
B
cell
consequent
ANCA
production.
Considering
their
crucial
initiating
fibrogenesis,
represent
logic
first-line
target
new
treatment
options
Brain,
Journal Year:
2021,
Volume and Issue:
144(9), P. 2709 - 2721
Published: April 10, 2021
Limbic
encephalitis
with
antibodies
against
adenylate
kinase
5
(AK5)
has
been
difficult
to
characterize
because
of
its
rarity.
In
this
study,
we
identified
10
new
cases
and
reviewed
16
previously
reported
patients,
investigating
clinical
features,
IgG
subclasses,
human
leucocyte
antigen
CSF
proteomic
profiles.
Patients
anti-AK5
limbic
were
mostly
male
(20/26,
76.9%)
a
median
age
66
years
(range
48-94).
The
predominant
symptom
was
severe
episodic
amnesia
in
all
frequently
associated
depression
(17/25,
68.0%).
Weight
loss,
asthenia
anorexia
also
highly
characteristic,
being
present
11/25
(44.0%)
patients.
Although
epilepsy
always
lacking
at
disease
onset,
seizures
developed
later
subset
patients
(4/25,
16.0%).
All
presented
abnormalities,
such
as
pleocytosis
(18/25,
72.0%),
oligoclonal
bands
72.0%)
increased
Tau
(11/14,
78.6%).
Temporal
lobe
hyperintensities
almost
onset
(23/26,
88.5%),
evolving
nearly
invariably
towards
atrophy
subsequent
MRIs
(17/19,
89.5%).
This
finding
line
poor
response
immunotherapy,
only
5/25
(20.0%)
responding.
IgG1
the
subclass,
most
detected
one
highest
titres
nine
CSF-serum
paired
samples.
A
temporal
biopsy
from
our
showed
massive
lymphocytic
infiltrates
dominated
by
both
CD4+
CT8+
T
cells,
intense
granzyme
B
expression
abundant
macrophages/microglia.
Human
(HLA)
analysis
11
striking
association
HLA-B*08:01
[7/11,
63.6%;
odds
ratio
(OR)
=
13.4,
95%
confidence
interval
(CI):
3.8-47.4],
C*07:01
(8/11,
72.7%;
OR
11.0,
CI:
2.9-42.5),
DRB1*03:01
14.4,
3.7-55.7),
DQB1*02:01
13.5,
3.5-52.0)
DQA1*05:01
3.7-55.7)
alleles,
which
formed
extended
haplotype
B8-C7-DR3-DQ2
6/11
(54.5%)
(OR
16.5,
4.8-57.1).
Finally,
compared
profile
five
that
40
control
subjects
other
more
common
non-paraneoplastic
(five
leucine-rich
glioma
inactivated
1
contactin-associated
protein-like
2),
well
paraneoplastic
neurological
syndromes
Yo
Ma2).
These
comparisons
revealed
31
seven
significantly
upregulated
proteins
encephalitis,
respectively
mapping
apoptosis
pathways
innate/adaptive
immune
responses.
findings
suggest
manifestations
result
distinct
cell-mediated
pathogenesis,
major
cytotoxicity-induced
leading
prompt
aggressive
neuronal
likely
explaining
prognosis
immunotherapy.
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
165, P. 115199 - 115199
Published: July 28, 2023
Chronic
wounds
and
scar
formation
are
widespread
due
to
limited
suitable
remedies.
The
macrophage
is
a
crucial
regulator
in
wound
healing,
controlling
the
onset
termination
of
inflammation
regulating
other
processes
related
healing.
current
breakthroughs
developing
new
medications
drug
delivery
methods
have
enabled
accurate
targeting
macrophages
oncology
rheumatic
disease
therapies
through
clinical
trials.
These
successes
cleared
way
utilize
drugs
various
disorders.
This
review
thus
summarizes
involvement
normal
pathologic
It
further
details
targets
available
for
intervention
therapeutic
strategies
behavior
tissue
repair
regeneration.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(14), P. 11251 - 11251
Published: July 8, 2023
Neuroinflammation
is
a
common
pathological
feature
of
amyotrophic
lateral
sclerosis
(ALS).
Although
scientific
evidence
to
date
does
not
allow
defining
neuroinflammation
as
an
ALS
trigger,
its
role
in
exacerbating
motor
neuron
(MNs)
degeneration
and
disease
progression
attracting
research
interest.
Activated
CNS
(Central
Nervous
System)
glial
cells,
proinflammatory
peripheral
infiltrated
T
lymphocytes
monocytes/macrophages,
well
the
immunoreactive
molecules
they
release,
represent
active
players
for
immune
dysregulation
enhancing
neuroinflammation.
The
crosstalk
between
cells
significantly
correlates
with
survival
patients
since
modification
macrophages
can
downregulate
inflammation
at
periphery
along
nerves
CNS.
As
putative
vehicles
misfolded
protein
inflammatory
mediators
extracellular
vesicles
(EVs)
have
also
drawn
particular
attention
field
ALS.
Both
release
EVs,
which
are
able
modulate
behavior
neighboring
recipient
cells;
unfortunately,
mechanisms
involved
EVs-mediated
communication
remain
unclear.
This
review
aims
synthesize
current
literature
regarding
EV-mediated
cell-to-cell
brain
under
ALS,
point
view
on
responding
understand
biological
process
exploit
it
management.